ArticleEuropean journal of ageing2026
Concurrent associations between objective markers and subjective markers of aging with indicators of successful aging: An integrative approach.
Article in European journal of ageing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive decline, immune function, and inflammation are considered objective markers of aging (OMAs) and are commonly used to predict an individual's aging success. We propose that subjective factors - such as a person's beliefs and perceptions about their own age and aging - that have been shown to predict development in old age be defined as subjective markers of aging (SMAs). Although aging is a complex, multidimensional process, studies typically examine effects of OMAS and SMAs separately, rather than integrating both types of markers to improve predictions of successful aging. Our study aims to fill this gap by concurrently using both OMAs and SMAs to model the associations of different indicators of successful aging, including autonomous daily functioning, health-related quality of life, and life satisfaction. We assess OMAs through measures of visuo-motoric speed and executive function (Trail Making Test), inflammation (interleukin-6, c-reactive protein), and immune aging (neutrophil-to-lymphocyte ratio). In addition, we examine SMAs by evaluating subjective age and self-perceptions of aging. We used cross-sectional data from 456 older adults (M
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.